ENDOCRINOLOGY | approach | physiology | basics | Harrison’s Endocrinology Series | by Dr Sudhir
Summary
This video introduces the basics of endocrinology, covering four modes of biological communication: endocrine, exocrine, paracrine, and autocrine. It details the hypothalamus-pituitary axis as the master regulator, hormone receptor interactions, and clinical implications of hormone crosstalk. The video also explores factors affecting hormone levels like circadian rhythms and sleep, pulsatile vs. continuous release, hormone half-lives, and dynamic testing. Finally, it touches upon hormone excess, deficiency, resistance, and genetic syndromes like Multiple Endocrine Neoplasia (MEN).
Key Insights
Hormone crosstalk between similar receptor types can lead to unexpected clinical effects.
Identical subunits in hormones like LH, FSH, TSH, and hCG can cause crosstalk. For instance, high hCG during pregnancy can stimulate TSH receptors, leading to gestational hyperthyroidism and suppressed TSH. Similarly, IGF-1 secreted by some sarcomas can cross-talk with insulin receptors, causing hypoglycemia. Tumors secreting parathyroid-related peptide can mimic PTH, causing hypercalcemia.
Hypothalamus controls pituitary hormone release, with exceptions like prolactin negatively regulated by dopamine.
The hypothalamus stimulates anterior pituitary release of GH, LH, FSH, prolactin, TSH, and ACTH, and posterior pituitary release of ADH and oxytocin. Most anterior pituitary hormones have positive hypothalamic stimulation (releasing hormones). Prolactin is unique, being negatively controlled by dopamine from hypothalamic dopaminergic neurons. Damage to the pituitary stalk leads to decreased levels of most pituitary hormones but increased prolactin.
Pulsatile hormone release upregulates receptor responsiveness, while continuous release causes downregulation.
The pulsatile release of hormones like GnRH upregulates receptor sensitivity. Conversely, continuous exposure leads to pituitary desensitization and receptor downregulation. This principle is clinically applied using long-acting GnRH agonists to suppress hormone levels by creating continuous exposure.
Dynamic testing (stimulation and suppression tests) is essential for evaluating hormonal dysfunction due to hormone volatility.
Due to the dynamic and often volatile nature of hormone levels, static measurements can be unreliable. Stimulation tests help assess hormone deficiency by attempting to provoke release from a gland, while suppression tests evaluate hormone excess by attempting to inhibit production. Failure to respond indicates dysfunction.
Sections
Modes of Biological Communication
Biological communication occurs via endocrine, exocrine, paracrine, or autocrine modes.
Biological communication primarily happens in four modes: 1. Endocrine: Hormone released into systemic blood (e.g., thyroid hormones). 2. Exocrine: Signal released into a lumen, like the gut (e.g., pepsin, renin). 3. Paracrine: Signal acts on adjacent cells (e.g., somatostatin inhibiting insulin secretion from adjacent B cells). 4. Autocrine: Signal acts on the same cell that released it (e.g., IGF-1 acting on chondrocytes).
Endocrine communication involves systemic hormone release, regulated by the hypothalamus and pituitary.
The endocrine system is primarily regulated by the hypothalamus, which controls the anterior and posterior pituitary. The pituitary then stimulates target endocrine tissues like the thyroid, adrenal, and gonads to release their hormones. These hormones act on effector cells via specific receptors.
Hormone interaction with effector cells occurs through various receptor types, including nuclear receptors for steroids.
Hormones interact with effector cells via multiple receptor types: G protein-coupled receptors (e.g., thyroid hormones), tyrosine kinase receptors (e.g., insulin), JAK-STAT receptors (e.g., growth hormone), serine protease receptors (e.g., TGF-beta), and nuclear receptors (e.g., steroidal hormones). While most surface/cytoplasmic interactions occur, steroidal hormones interact directly within the nucleus.
Hormone Crosstalk and Clinical Implications
Hormone crosstalk between similar receptor types can lead to unexpected clinical effects.
Identical subunits in hormones like LH, FSH, TSH, and hCG can cause crosstalk. For instance, high hCG during pregnancy can stimulate TSH receptors, leading to gestational hyperthyroidism and suppressed TSH. Similarly, IGF-1 secreted by some sarcomas can cross-talk with insulin receptors, causing hypoglycemia. Tumors secreting parathyroid-related peptide can mimic PTH, causing hypercalcemia.
Crosstalk between nuclear receptors, though minimal, occurs between glucocorticoids and mineralocorticoids.
While hormones interacting via nuclear receptors show less crosstalk, some glucocorticoids can exert mineralocorticoid activity, and vice-versa, due to shared receptors. This interaction is mediated through common receptor pathways.
Hypothalamus-Pituitary Axis and Hormone Release
Hypothalamus controls pituitary hormone release, with exceptions like prolactin negatively regulated by dopamine.
The hypothalamus stimulates anterior pituitary release of GH, LH, FSH, prolactin, TSH, and ACTH, and posterior pituitary release of ADH and oxytocin. Most anterior pituitary hormones have positive hypothalamic stimulation (releasing hormones). Prolactin is unique, being negatively controlled by dopamine from hypothalamic dopaminergic neurons. Damage to the pituitary stalk leads to decreased levels of most pituitary hormones but increased prolactin.
Pituitary gland's location is identifiable on neuroimaging above the basal cistern or in front of the brainstem.
In axial neuroimaging, the pituitary is located just above the star-shaped basal cistern. In sagittal view, it appears to sit in front of the bird-like brainstem structure. This is crucial for identifying pituitary structural abnormalities.
Factors Modulating Hormone Levels
Circadian rhythms, sleep, and stress significantly impact hormone secretion patterns.
Environmental factors like circadian rhythms and sleep influence hormone release. Growth hormone peaks during deep sleep and is triggered by fasting, exercise, and stress. Cortisol levels are highest from midnight to morning. Prolactin release is linked to sleep cycles (higher in NREM, suppressed in REM), making sleep deprivation detrimental.
Pulsatile hormone release upregulates receptor responsiveness, while continuous release causes downregulation.
The pulsatile release of hormones like GnRH upregulates receptor sensitivity. Conversely, continuous exposure leads to pituitary desensitization and receptor downregulation. This principle is clinically applied using long-acting GnRH agonists to suppress hormone levels by creating continuous exposure.
Longer hormone half-lives allow for simpler dosing and stable levels, but require longer time to reach steady state.
Hormones like T4 have long half-lives (approx. 7 days), meaning steady state is reached in 4-5 half-lives (4-5 weeks). This allows for once-daily dosing and flexibility if doses are missed. T3, with a 1-day half-life, requires multiple daily doses and shows volatile serum levels. TSH, despite pulsatile secretion, has a long half-life, making random serum samples sufficient for monitoring.
Dynamic testing (stimulation and suppression tests) is essential for evaluating hormonal dysfunction due to hormone volatility.
Due to the dynamic and often volatile nature of hormone levels, static measurements can be unreliable. Stimulation tests help assess hormone deficiency by attempting to provoke release from a gland, while suppression tests evaluate hormone excess by attempting to inhibit production. Failure to respond indicates dysfunction.
Hormone assays can be unreliable due to receptor mutations, altered binding protein levels, or physiological factors.
Activating receptor mutations can lead to hormone production even with normal or low hormone levels. Most hormones circulate bound to proteins (e.g., T4 to TBG); variations in these binding proteins affect total hormone levels, making free hormone measurements crucial. Physiological factors like sleep, fasting, exercise, obesity, and steroid use also dynamically alter hormone levels, necessitating dynamic testing over single measurements.
Endocrine System Pathologies and Syndromes
Endocrine disorders manifest as hormone excess, deficiency, or resistance to hormone action.
Pathologies include hormone excess (due to tumors, autoimmune stimulation, or exogenous intake), hormone deficiency (due to glandular destruction, infarction, infection, or tumors), and hormonal resistance (e.g., Type 2 diabetes with receptor signaling defects). Feedback loop defects are common in excess states.
Multiple Endocrine Neoplasia (MEN) syndromes involve genetic predispositions to tumors in multiple endocrine glands.
MEN syndromes are genetic disorders affecting multiple endocrine glands. MEN1 involves the MEN1 gene leading to tumors of the pancreas, pituitary, and parathyroids. MEN2 involves the RET proto-oncogene, affecting the thyroid (medullary carcinoma), pheochromocytoma, and parathyroids (MEN2A) or mucosal abnormalities (MEN2B). MEN4 resembles MEN1 with added reproductive system tumors.
Neuroendocrine axes utilize positive and negative feedback loops for hormonal regulation.
The neuroendocrine axis involves complex feedback mechanisms. For example, steroids negatively feedback on CRH, while inflammatory cytokines stimulate it. This leads to the production of POMC precursor, which generates ACTH, beta-lipoprotein, beta-endorphins, and alpha-MSH, influencing corticosteroids, metabolism, pain, and pigmentation respectively. Dysregulation impacts these processes.
Ask a Question
*Uses 1 Wisdom coin from your coin balance
